Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
3.660
-0.730 (-16.63%)
At close: Jun 16, 2025, 4:00 PM
3.600
-0.060 (-1.64%)
After-hours: Jun 16, 2025, 6:49 PM EDT

Aptevo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
2231238160
Upgrade
Market Cap Growth
-32.30%-36.70%-71.09%-69.34%-75.96%441.40%
Upgrade
Enterprise Value
5-0-10-06163
Upgrade
Last Close Price
3.6686.205893.3775539.28256247.461193325.19
Upgrade
PE Ratio
---1.47--
Upgrade
PS Ratio
---3.783.1337.11
Upgrade
PB Ratio
-0.450.280.6631.619.64
Upgrade
P/TBV Ratio
-0.450.280.6631.619.64
Upgrade
EV/Sales Ratio
----0.4637.90
Upgrade
Debt / Equity Ratio
-3.001.140.440.5513.751.65
Upgrade
Asset Turnover
---0.070.220.08
Upgrade
Quick Ratio
0.401.402.342.891.402.91
Upgrade
Current Ratio
0.671.722.643.151.513.25
Upgrade
Return on Equity (ROE)
-1023.93%-284.28%-123.53%73.10%-330.24%-217.49%
Upgrade
Return on Assets (ROA)
-115.99%-76.06%-61.12%-39.42%-24.29%-32.13%
Upgrade
Return on Capital (ROIC)
-201.28%-110.74%-79.25%-78.06%-43.19%-43.48%
Upgrade
Earnings Yield
-956.92%-1119.01%-511.13%68.12%-74.03%-11.10%
Upgrade
FCF Yield
-957.13%-1103.01%-344.36%-178.64%-58.26%-18.39%
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q